South Korea Prefilled Syringes Market Size, Share, and COVID-19 Impact Analysis, By Material (Glass Prefilled Syringes, Plastic Prefilled Syringes), By Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, Customized Prefilled Syringes), and South Korea Prefilled Syringes Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI12256
PAGES 220
REPORT FORMAT PathSoft

South Korea Prefilled Syringes Market Insights Forecasts to 2035

  • The South Korea Prefilled Syringes Market Size was estimated at USD 146.4 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 4.80% from 2025 to 2035
  • The South Korea Prefilled Syringes Market Size is Expected to Reach USD 245.2 Million by 2035

South Korea Prefilled Syringes Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, the South Korea Prefilled Syringes Market is anticipated to reach USD 245.2 million by 2035, growing at a CAGR of 4.80% from 2025 to 2035. Some of the major factors driving the market growth include the impact of the COVID-19 pandemic, increased awareness among healthcare professionals, stricter regulations, a greater emphasis on patient safety, the ease of access to affordable healthcare solutions, rapid biotechnology advancements, the rising prevalence of chronic diseases, increased government support and investments, and more.

 

Market Overview

The industry that includes the creation, manufacturing, and distribution of syringes that are pre-filled with drugs and intended for single-use administration is known as the South Korea prefilled syringes market. These tools are essential for improving medication adherence, increasing patient safety, and administering exact dosages of medications. Additionally, the South Korea prefilled syringes market is influenced by several key drivers, such as the increasing prevalence of chronic diseases and the growing aging population. Furthermore, stringent regulatory requirements for drug delivery systems have made prefilled syringes an attractive choice for pharmaceutical companies seeking regulatory compliance, which is accelerating the market growth. Furthermore, the emphasis on reducing medication errors and enhancing patient safety has propelled the adoption of prefilled syringes in healthcare settings, further stimulating the market growth.

 

Report Coverage

This research report categorizes the market for the South Korea prefilled syringes market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea prefilled syringes market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea prefilled syringes market.

 

South Korea Prefilled Syringes Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 146.4 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :4.80%
2035 Value Projection:USD 245.2 Million
Historical Data for:2020-2023
No. of Pages:220
Tables, Charts & Figures:126
Segments covered:By Material, By Design and COVID-19 Impact Analysis
Companies covered:: Samsung Biologics, Celltrion, Becton, Dickinson and Company (BD), Gerresheimer AG, Schott AG, Nipro Corporation, Others.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis.

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The emphasis on efficiency and cost-effectiveness in the South Korean healthcare system has led medical professionals to use prefilled syringes as a way to cut costs. Aside from this, the need for accurate drug delivery and the substantial research and development (R&D) activities in the biotechnology and biopharmaceuticals fields have sparked investment and innovation in prefilled syringe technology, which is driving market expansion. Additionally, the country's market is expanding as a result of growing patient and healthcare professional awareness of the advantages of prefilled syringes, including lower contamination risks and better patient compliance.

 

Restraining Factors

Defects in syringe components, contamination, and sterility assurance failures have all resulted in product recalls. Such recalls undermine consumer confidence in prefilled syringe products and harm manufacturers' reputations in addition to compromising patient safety.

 

Market Segmentation

The South Korea prefilled syringes market share is classified into material and design.

 

  • The glass prefilled syringes segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea prefilled syringes market is segmented by material into glass prefilled syringes and plastic prefilled syringes. Among these, the glass prefilled syringes segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The biocompatibility, chemical resistance, and long-term drug stability of glass syringes make them the preferred option.

 

  • The single-chamber prefilled syringe segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea prefilled syringes market is segmented by design into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Among these, the single-chamber prefilled syringe segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Given its extensive use in the administration of numerous medications, such as vaccines, insulin, and biologics, this segment commands a sizeable portion of the market. Single-chamber syringes are the go-to option in both hospital and outpatient settings due to their simplicity, affordability, and ease of use.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea prefilled syringes market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Samsung Biologics
  • Celltrion
  • Becton, Dickinson and Company (BD)
  • Gerresheimer AG
  • Schott AG
  • Nipro Corporation
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Prefilled Syringes Market based on the below-mentioned segments:

 

South Korea Prefilled Syringes Market, By Material

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

 

South Korea Prefilled Syringes Market, By Design

  • Single-chamber Prefilled Syringes
  • Dual-chamber Prefilled Syringes
  • Customized Prefilled Syringes

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies